Clinical Trial Update: Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 trial of Imatinib (Gleevec) in selected patients with metastatic melanoma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Peking University | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED